Pfizer lung cancer drug beats chemo for previously untreated patients
(Reuters) - Pfizer Inc's Xalkori delayed progression of lung cancer longer than chemotherapy in patients who had never previously been treated for the...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/niFNi48UtFk/story01.htm
No comments:
Post a Comment